US Patent Issued to CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITEDE LIMOGES on May 6 for "Chimeric protein in the treatment of amyloidosis" (French Inventors)

ALEXANDRIA, Va., June 10 -- United States Patent no. 12,291,552, issued on May 6, was assigned to CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Paris) and UNIVERSITEDE LIMOGES (Limoges, France).

"Chimeric protein in the treatment of amyloidosis" was invented by Christophe De Romeuf (Lambersart, France), Christophe Sirac (Limoges, France) and Jean-Claude Brouet (Paris).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a chimeric protein comprising at least one human amyloid P component and at least one fragment of an Fc region of a human antibody, the human amyloid P component and the fragment of an Fc region with which it is associated being bound to each other by means of...